TrialHuman vaccines & immunotherapeutics2018

MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico.

Aurelio Cruz-Valdez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.